BETA
Cleveland medical device company developing wireless surgical visualization systems for arthroscopy and endoscopy.
Lazurite is a Cleveland, Ohio medical device company founded in 2015 and led by Chair and CEO Mark Froimson, MD. Its ArthroFree platform combines a wireless surgical camera, integrated illumination and video transmission for minimally invasive procedures.
The current ArthroFree 2 offering includes a 1080p camera head, Meridiem lighting technology, a wireless receiver and rechargeable batteries. It transmits video using encrypted ultra-wideband technology and is designed to work with compatible endoscopes and surgical displays. Lazurite also offers configurations for office and clinic endoscopy.
The company’s technology portfolio centers on surgical imaging, wireless communication and low-heat illumination. Minnetronix Medical supported ArthroFree’s development and manufacturing scale-up ahead of its first human use in September 2022.
FDA cleared the ArthroFree Wireless Surgical Camera System under 510(k) K213860 on March 23, 2022, with Lazurite Holdings, LLC as the applicant. The Class II system supplies illumination and visualization for diagnostic and operative endoscopic procedures, including arthroscopy, general laparoscopy and ENT applications. [7]
Lazurite now markets ArthroFree 2 with updated lighting, image processing and display controls, alongside clinic endoscopy configurations. The 2022 FDA decision identifies the original ArthroFree system; the newer commercial name is retained separately from the clearance’s original device name. [1][6][7]
Latest recorded source review: 2026-11-03.
Scope: selected product families.
Documented commercial product families.
ArthroFree combines a wireless camera, integrated illumination, receiver and rechargeable batteries to provide endoscopic video. The current ArthroFree 2 configuration adds updated Meridiem lighting and image processing; the company also markets clinic endoscopy setups. [7][1][6]
Commercially available · ArthroFree product familyLazurite announced its March 2026 AAOS exhibit featuring ArthroFree 2. [2]
Company announced appointment as Chief Financial and Development Officer. [4]
Lazurite reported first human use at NYU Langone; its September21 announcement also described completion of manufacturing transfer with Minnetronix. [3]
FDA cleared the wireless surgical camera system under K213860. [7]
Accessed 11/03/2026
Last substantive review: 11/3/2026